Free Trial
→ You cannot escape this reality (From Porter & Company) (Ad)tc pixel Free MBX Stock Alerts

Microbix Biosystems (MBX) Competitors

Microbix Biosystems logo
C$0.26 +0.01 (+4.00%)
As of 05/25/2026 03:59 PM Eastern
Compare

MBX vs. HBP, SCYB, COM, NVH, and IGX

Should you buy Microbix Biosystems stock or one of its competitors? MarketBeat compares Microbix Biosystems with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Microbix Biosystems include Helix BioPharma (HBP), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), and IntelGenx Technologies (IGX). These companies are all part of the "biotechnology" industry.

How does Microbix Biosystems compare to Helix BioPharma?

Microbix Biosystems (TSE:MBX) and Helix BioPharma (TSE:HBP) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

Helix BioPharma has a net margin of 0.00% compared to Microbix Biosystems' net margin of -38.62%. Microbix Biosystems' return on equity of -21.02% beat Helix BioPharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Microbix Biosystems-38.62% -21.02% 3.82%
Helix BioPharma N/A -36.79%-279.98%

Microbix Biosystems has higher revenue and earnings than Helix BioPharma. Helix BioPharma is trading at a lower price-to-earnings ratio than Microbix Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbix BiosystemsC$16.76M2.13C$3.39M-C$0.03N/A
Helix BioPharmaN/AN/A-C$50.55M-C$0.06N/A

In the previous week, Microbix Biosystems had 1 more articles in the media than Helix BioPharma. MarketBeat recorded 1 mentions for Microbix Biosystems and 0 mentions for Helix BioPharma. Microbix Biosystems' average media sentiment score of 0.00 equaled Helix BioPharma'saverage media sentiment score.

Company Overall Sentiment
Microbix Biosystems Neutral
Helix BioPharma Neutral

0.2% of Microbix Biosystems shares are held by institutional investors. Comparatively, 0.0% of Helix BioPharma shares are held by institutional investors. 14.0% of Microbix Biosystems shares are held by company insiders. Comparatively, 2.2% of Helix BioPharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Microbix Biosystems has a beta of 0.483573, suggesting that its share price is 52% less volatile than the broader market. Comparatively, Helix BioPharma has a beta of 0.403644, suggesting that its share price is 60% less volatile than the broader market.

Summary

Microbix Biosystems beats Helix BioPharma on 10 of the 11 factors compared between the two stocks.

How does Microbix Biosystems compare to Scythian Biosciences?

Scythian Biosciences (CVE:SCYB) and Microbix Biosystems (TSE:MBX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, valuation, earnings, analyst recommendations, institutional ownership and profitability.

0.2% of Microbix Biosystems shares are owned by institutional investors. 14.0% of Microbix Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Scythian Biosciences has a net margin of 0.00% compared to Microbix Biosystems' net margin of -38.62%. Scythian Biosciences' return on equity of 0.00% beat Microbix Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Scythian BiosciencesN/A N/A N/A
Microbix Biosystems -38.62%-21.02%3.82%

Microbix Biosystems has higher revenue and earnings than Scythian Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scythian BiosciencesN/AN/AN/AN/AN/A
Microbix BiosystemsC$16.76M2.13C$3.39M-C$0.03N/A

In the previous week, Microbix Biosystems had 1 more articles in the media than Scythian Biosciences. MarketBeat recorded 1 mentions for Microbix Biosystems and 0 mentions for Scythian Biosciences. Scythian Biosciences' average media sentiment score of 0.00 equaled Microbix Biosystems'average media sentiment score.

Company Overall Sentiment
Scythian Biosciences Neutral
Microbix Biosystems Neutral

Summary

Microbix Biosystems beats Scythian Biosciences on 5 of the 7 factors compared between the two stocks.

How does Microbix Biosystems compare to 138267 (COM.TO)?

Microbix Biosystems (TSE:MBX) and 138267 (COM.TO) (TSE:COM) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, media sentiment, analyst recommendations and profitability.

138267 (COM.TO) has a net margin of 0.00% compared to Microbix Biosystems' net margin of -38.62%. 138267 (COM.TO)'s return on equity of 0.00% beat Microbix Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Microbix Biosystems-38.62% -21.02% 3.82%
138267 (COM.TO) N/A N/A N/A

In the previous week, Microbix Biosystems had 1 more articles in the media than 138267 (COM.TO). MarketBeat recorded 1 mentions for Microbix Biosystems and 0 mentions for 138267 (COM.TO). Microbix Biosystems' average media sentiment score of 0.00 equaled 138267 (COM.TO)'saverage media sentiment score.

Company Overall Sentiment
Microbix Biosystems Neutral
138267 (COM.TO) Neutral

0.2% of Microbix Biosystems shares are held by institutional investors. 14.0% of Microbix Biosystems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Microbix Biosystems has higher revenue and earnings than 138267 (COM.TO).

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbix BiosystemsC$16.76M2.13C$3.39M-C$0.03N/A
138267 (COM.TO)N/AN/AN/AN/AN/A

Summary

Microbix Biosystems beats 138267 (COM.TO) on 5 of the 7 factors compared between the two stocks.

How does Microbix Biosystems compare to Novoheart?

Novoheart (CVE:NVH) and Microbix Biosystems (TSE:MBX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations.

0.2% of Microbix Biosystems shares are held by institutional investors. 14.0% of Microbix Biosystems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Microbix Biosystems has higher revenue and earnings than Novoheart. Novoheart is trading at a lower price-to-earnings ratio than Microbix Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NovoheartC$423.50K236.08-C$7.17M-C$0.04N/A
Microbix BiosystemsC$16.76M2.13C$3.39M-C$0.03N/A

Novoheart has a net margin of 0.00% compared to Microbix Biosystems' net margin of -38.62%. Novoheart's return on equity of 0.00% beat Microbix Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
NovoheartN/A N/A N/A
Microbix Biosystems -38.62%-21.02%3.82%

In the previous week, Microbix Biosystems had 1 more articles in the media than Novoheart. MarketBeat recorded 1 mentions for Microbix Biosystems and 0 mentions for Novoheart. Novoheart's average media sentiment score of 0.00 equaled Microbix Biosystems'average media sentiment score.

Company Overall Sentiment
Novoheart Neutral
Microbix Biosystems Neutral

Summary

Microbix Biosystems beats Novoheart on 8 of the 11 factors compared between the two stocks.

How does Microbix Biosystems compare to IntelGenx Technologies?

Microbix Biosystems (TSE:MBX) and IntelGenx Technologies (CVE:IGX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings, media sentiment and valuation.

0.2% of Microbix Biosystems shares are owned by institutional investors. 14.0% of Microbix Biosystems shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

IntelGenx Technologies has a net margin of 0.00% compared to Microbix Biosystems' net margin of -38.62%. IntelGenx Technologies' return on equity of 0.00% beat Microbix Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Microbix Biosystems-38.62% -21.02% 3.82%
IntelGenx Technologies N/A N/A N/A

In the previous week, Microbix Biosystems had 1 more articles in the media than IntelGenx Technologies. MarketBeat recorded 1 mentions for Microbix Biosystems and 0 mentions for IntelGenx Technologies. Microbix Biosystems' average media sentiment score of 0.00 equaled IntelGenx Technologies'average media sentiment score.

Company Overall Sentiment
Microbix Biosystems Neutral
IntelGenx Technologies Neutral

Microbix Biosystems has higher revenue and earnings than IntelGenx Technologies. Microbix Biosystems is trading at a lower price-to-earnings ratio than IntelGenx Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbix BiosystemsC$16.76M2.13C$3.39M-C$0.03N/A
IntelGenx TechnologiesC$1.75M49.95-C$11.74M-C$0.08N/A

Summary

Microbix Biosystems beats IntelGenx Technologies on 7 of the 11 factors compared between the two stocks.

Get Microbix Biosystems News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MBX vs. The Competition

Export
MetricMicrobix BiosystemsBiotechnology IndustryMedical SectorTSE Exchange
Market CapC$35.75MC$470.59MC$6.46BC$12.16B
Dividend Yield2.30%3.87%2.76%6.20%
P/E Ratio-8.673.8621.2137.64
Price / Sales2.137,288.62554.3811.68
Price / Cash4.1313.1343.4982.29
Price / Book1.4384.7810.374.50
Net IncomeC$3.39M-C$96.07MC$3.57BC$299.09M
7 Day Performance13.04%0.05%6.40%2.48%
1 Month Performance6.12%0.57%3.53%1.47%
1 Year Performance-23.53%63.42%34.04%53.55%

Microbix Biosystems Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MBX
Microbix Biosystems
N/AC$0.26
+4.0%		N/A-23.5%C$35.75MC$16.76MN/AN/A
HBP
Helix BioPharma
N/AC$1.60
-1.8%		N/AN/AC$122.21MN/AN/A9
SCYB
Scythian Biosciences
N/AC$3.49
-5.9%		N/A+0.0%C$102.38MN/AN/AN/A
COM
138267 (COM.TO)
N/AN/AN/AN/AC$102.19MN/AN/AN/A
NVH
Novoheart
N/AC$0.53
+1.9%		N/A+0.0%C$99.98MC$423.50KN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:MBX) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
Trump Admin to Pump $1 Billion into this “Off-the-Radar” AI Stock
The U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into...
InvestorPlace | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
Your book attached
Bill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...
Profits Run | Sponsoredtc pixel
Gold surged 600 dollars last time this indicator peaked
The Buffett Indicator has predicted every major gold bull run this century - 2000, 2008, and 2020, when gold s...
Porter & Company | Sponsoredtc pixel
Opportunity Forming in a U.S. Supply-Chain Weak Spot?
America has a supply-chain problem with graphite - demand is climbing while dependence on foreign sources rema...
i2i Marketing Group, LLC | Sponsoredtc pixel